The Albumin in Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: safety and neurologic outcomes

Human albumin has been shown to exert neuroprotective effects in animal models of cerebral ischemia and humans with various intracranial pathologies. We investigated the safety and tolerability of 25% human albumin in patients with subarachnoid hemorrhage. The Albumin in Subarachnoid Hemorrhage (ALI...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Stroke (1970) Jg. 43; H. 3; S. 683
Hauptverfasser:	Suarez, Jose I, Martin, Renee H, Calvillo, Eusebia, Dillon, Catherine, Bershad, Eric M, Macdonald, R Loch, Wong, John, Harbaugh, Robert
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 01.03.2012
Schlagworte:	Acute Disease Adult Aged Albumins - adverse effects Albumins - therapeutic use Blood Pressure - physiology Cardiovascular Diseases - chemically induced Cardiovascular Diseases - epidemiology Data Interpretation, Statistical Disability Evaluation Dose-Response Relationship, Drug Female Follow-Up Studies Glasgow Outcome Scale Humans Male Middle Aged Nervous System Diseases - etiology Nervous System Diseases - prevention & control Neuroprotective Agents - adverse effects Neuroprotective Agents - therapeutic use Patient Care Management Pilot Projects Respiratory Tract Diseases - chemically induced Respiratory Tract Diseases - epidemiology Sample Size Subarachnoid Hemorrhage - complications Subarachnoid Hemorrhage - drug therapy Subarachnoid Hemorrhage - psychology Treatment Outcome
ISSN:	1524-4628, 1524-4628
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!